BridgeBio Oncology Therapeutics Income Statement (2023-2026) | BBOT

Income Statement Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & Cost
Interest income
Interest Income - Total (Quarter) 2.47M2.13M1.81M3.44M4.42M3.94M3.55M
Interest expenses
Interest Expenses (Quarter) 45.18M35.84M42.77M15.91M10.62M
Interest Income - Net (Quarter) 2.47M-43.05M1.81M-32.40M-38.35M-11.96M-7.07M
Non-interest income
Investment Gain (Loss) (Quarter) 0.00M0.00M0.00M0.00M
Non-Interest Income (Quarter) 0.00M0.00M0.00M0.00M
Operating Items
Research & Development (Quarter) 17.89M19.54M20.64M35.05M38.07M39.80M49.23M
Selling, General & Administrative (Quarter) 0.07M0.15M1.77M2.34M2.50M1.12M7.80M5.33M6.38M10.96M
Other Operating Expenses (Quarter) 6.33M16.82M
Operating Expenses (Quarter) 0.07M0.15M19.66M21.88M23.14M1.12M49.18M43.41M46.18M60.19M
Operating Income (Quarter) -0.07M-0.15M-19.66M-21.88M-23.14M-1.12M-49.18M-43.41M-46.18M-60.19M
EBIT (Quarter) -0.07M-0.15M-19.66M-21.88M-23.14M-1.12M-49.18M-43.41M-46.18M-60.19M
Non-operating items
Non Operating Investment Income (Quarter) -0.06M-0.16M-0.14M-1.00M
Interest & Investment Income (Quarter) 1.21M2.44M2.55M2.25M1.99M2.07M
Other Non Operating Income (Quarter) -0.00M-0.03M-0.01M-0.09M-0.01M
Non Operating Income (Quarter) 1.17M2.36M2.34M2.19M1.08M2.04M4.42M4.61M4.07M3.73M
Net income details
EBT (Quarter) 1.14M2.29M-17.11M-64.81M-21.15M0.95M-85.02M-86.18M-62.09M-70.81M
Profit After Tax (Quarter) -15.44M-21.82M-17.32M-19.71M-22.10M-28.43M-44.76M-38.75M-42.11M-56.50M
Income from Continuing Operations (Quarter) 1.14M2.29M-17.11M-64.81M-21.15M0.95M-85.02M-86.18M-62.09M-70.81M
Consolidated Net Income (Quarter) 1.14M2.29M-17.11M-64.81M-21.15M0.95M-85.02M-86.18M-62.09M-70.81M
Income towards Parent Company (Quarter) 1.14M2.29M-17.11M-64.81M-21.15M0.95M-85.02M-86.18M-62.09M-70.81M
Net Income towards Common Stockholders (Quarter) 0.77M1.78M1.88M-2.77M-0.39M0.18M-85.02M-86.18M-62.09M-70.81M
Additional items
EPS (Basic) (Quarter) 0.080.090.10-0.17-0.020.01-1.95-2.77-775.78-0.88
EPS (Diluted) (Quarter) 0.080.090.10-0.17-0.020.01-1.95-2.77-775.78-0.88
Shares Outstanding (Quarter) 4.00M9.87M18.91M18.91M16.64M18.91M18.91M43.49M31.14M0.08M80.05M
Shares Outstanding (Diluted) (Quarter) 4.00M9.87M18.91M18.91M16.64M18.91M18.91M43.49M31.14M0.08M80.05M
Shares Outstanding (Entity) (Quarter) 4.60M9.87M18.91M18.91M16.64M18.91M18.91M43.49M31.14M0.08M80.17M
EBITDA (Quarter) -0.07M-0.15M-19.66M-21.88M-23.14M-1.12M-49.18M-43.41M-46.18M-60.19M